ATE244560T1 - Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil - Google Patents

Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil

Info

Publication number
ATE244560T1
ATE244560T1 AT00909562T AT00909562T ATE244560T1 AT E244560 T1 ATE244560 T1 AT E244560T1 AT 00909562 T AT00909562 T AT 00909562T AT 00909562 T AT00909562 T AT 00909562T AT E244560 T1 ATE244560 T1 AT E244560T1
Authority
AT
Austria
Prior art keywords
dosage form
oral dosage
axetil
cefuroxim
producing
Prior art date
Application number
AT00909562T
Other languages
English (en)
Inventor
Jitendra Krishan Somani
Indu Bhushan
Himadri Sen
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN453DE1999 external-priority patent/IN190831B/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of ATE244560T1 publication Critical patent/ATE244560T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
AT00909562T 1999-03-19 2000-03-17 Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil ATE244560T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN453DE1999 IN190831B (de) 1999-03-19 1999-03-19
US09/366,986 US6346530B1 (en) 1999-03-19 1999-08-04 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
PCT/IB2000/000292 WO2000056286A1 (en) 1999-03-19 2000-03-17 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil

Publications (1)

Publication Number Publication Date
ATE244560T1 true ATE244560T1 (de) 2003-07-15

Family

ID=26324612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00909562T ATE244560T1 (de) 1999-03-19 2000-03-17 Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil

Country Status (10)

Country Link
US (1) US6323193B1 (de)
EP (1) EP1165051B1 (de)
AT (1) ATE244560T1 (de)
AU (1) AU3184300A (de)
BR (1) BR0009177A (de)
CA (1) CA2366617A1 (de)
ES (1) ES2202069T3 (de)
HK (1) HK1043540B (de)
PT (1) PT1165051E (de)
WO (1) WO2000056286A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20033456A3 (en) * 2001-06-22 2004-07-14 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
WO2005002540A2 (en) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Dry powder pharmaceutical suspension compositions of cefuroxime axetil
GB0400971D0 (en) * 2004-01-16 2004-02-18 Sandoz Ag Pharmaceutical compositions
US8188067B2 (en) 2004-04-01 2012-05-29 Teva Pharmaceutical Industries Ltd. Formulations of 6-mercaptopurine
CA2560654A1 (en) * 2004-04-01 2006-09-20 Teva Pharmaceutical Industries Ltd. Imroved formulations of 6-mercaptopurine
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
WO2007063552A1 (en) * 2005-12-02 2007-06-07 Lupin Limited Stable taste masked formulations of cephalosporins
US20090263482A1 (en) * 2008-04-18 2009-10-22 Vered Rosenberger Treatment of inflammatory bowel disease with 6-mercaptopurine
US20100056825A1 (en) * 2008-08-28 2010-03-04 Telik, Inc. Formulations of canfosfamide and their preparation
US8324426B2 (en) * 2008-08-28 2012-12-04 Telik, Inc. Formulations of canfosfamide and their preparation
EP2566458B1 (de) * 2010-05-04 2015-08-05 Mahmut Bilgic Pharmazeutische formulierungen mit cefuroxim-axetil
WO2013100880A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Formulations comprising cefuroxime
US8313774B1 (en) * 2012-06-26 2012-11-20 Magnifica Inc. Oral solid composition
US20170105996A1 (en) 2015-10-16 2017-04-20 Teva Pharmaceutical Industries, Ltd. Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine
KR20200109291A (ko) * 2017-08-18 2020-09-22 애브비 인코포레이티드 자궁내막증, 자궁섬유증, 다낭난소증후군 또는 샘근육증을 치료하기 위한 약제학적 제형
US12083227B2 (en) 2017-08-18 2024-09-10 Abbvie Inc. Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
KR100187959B1 (ko) * 1997-03-31 1999-06-01 윤재승 저융점 무정형 세푸록심 악세틸의 제조방법
IN186539B (de) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
EP1165051A1 (de) 2002-01-02
HK1043540B (en) 2003-12-24
WO2000056286A1 (en) 2000-09-28
EP1165051B1 (de) 2003-07-09
AU3184300A (en) 2000-10-09
BR0009177A (pt) 2002-01-22
PT1165051E (pt) 2003-11-28
ES2202069T3 (es) 2004-04-01
CA2366617A1 (en) 2000-09-28
HK1043540A1 (en) 2002-09-20
US6323193B1 (en) 2001-11-27

Similar Documents

Publication Publication Date Title
ATE244560T1 (de) Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil
ATE478665T1 (de) Verfahren zur herstellung einer polymorphen form von atorvastatin calcium
DE69227170D1 (de) Verfahren zur Herstellung von Verbundhalbleitern des P-Typs
DE60015228D1 (de) Verfahren zur Herstellung von kristallinem Silizium
DE69913071D1 (de) Verfahren zur Herstellung von veresterten Verbindungen
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
DE60223659D1 (de) Einstufiges verfahren zur herstellung von kaugummi
DE69826604D1 (de) Verfahren zur fermentativen herstellung von deacylierten cephalosporinen
DE69621297D1 (de) Verfahren zur Herstellung wasserlöslicher organischer Silizium-Verbindungen
DE59603052D1 (de) Verfahren zur Herstellung teilmetallisierter Gitterstrukturen
DE69604452D1 (de) Verfahren zur Herstellung polykristalliner Halbleiter
DE69429335D1 (de) Verfahren zur Herstellung stabiler wässriger Silan-Zusammensetzungen
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
DE69623585D1 (de) Verfahren zur Herstellung polykristalliner Halbleiter
DE69233106D1 (de) Verfahren zur Herstellung von Einzelsträndigen "stem-loop" DNS
ATE246196T1 (de) Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon
DE69910648D1 (de) Verfahren zur Herstellung von schwefelenthaltende organosiliziumverbindungen
DE60024210D1 (de) Verfahren zur Herstellung von Zahnrädern
ATE250601T1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
DE60008830D1 (de) Verfahren zur Herstellung von keramischen Zusammensetzungen
DE59607629D1 (de) Verfahren zur Herstellung polycyclischer Verbindungen
DE69319296D1 (de) Verfahren zur Reinigung von roher Clavulansäure
DE59603826D1 (de) Verfahren zur kontinuierlichen Herstellung von macrocyclischen Verbindungen
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE59208484D1 (de) Verfahren zur Herstellung von Polykondensaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165051

Country of ref document: EP

REN Ceased due to non-payment of the annual fee